CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 6 Months Ended |
Oct. 31, 2016 | Oct. 31, 2015 |
Operating activities: | | |
Net income (loss) from operations | $ 138,220 | $ (1,956,498) |
Consolidated net income from discontinued operations | 0 | 878,981 |
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 48,695 | 14,969 |
Shares based compensation | 22,501 | 1,540,181 |
Gain on sale of China operations | 0 | (837,720) |
Income on Section 16 settlement | 0 | (400,000) |
Changes in operating assets and liabilities: | | |
Accounts receivable | (324,990) | 2,407,532 |
Costs and estimated earnings in excess of billings on uncompleted contracts | (372,408) | (165,287) |
Current assets held for sale | 0 | (3,853,621) |
Prepaid expenses and other current assets | (46,908) | 92,677 |
Other assets | 1,999 | 0 |
Other assets held for sale | 0 | (34,523) |
Accounts payable and accrued expenses | 143,477 | (2,653,981) |
Current liabilities held for sale | 0 | 2,200,030 |
Billings in excess of costs and estimated earnings on uncompleted contracts | 372,707 | 203,039 |
Net cash used in operating activities | (16,707) | (2,564,221) |
Investing activities: | | |
Acquisition of property and equipment | (96,475) | 0 |
Proceeds from sale of China operations, net of acquisition cost | 0 | 1,325,744 |
Net cash (used in) provided by investing activities | (96,475) | 1,325,744 |
Financing activities: | | |
Proceeds from issuance of Series H-1 preferred stock and warrants | 0 | 1,575,000 |
Borrowings under loan payable obligations | 0 | 7,762 |
Repayment under loan payable obligations | (52,027) | (10,837) |
Repayments under other payable to Zurich | 0 | (270,000) |
Repayments of short term convertible note | 0 | (4,000) |
Net cash (used in) provided by financing activities | (52,027) | 1,297,925 |
Effect of exchange rate changes on cash | 0 | 91,510 |
Net (decrease) increase in cash and cash equivalents | (165,209) | 150,958 |
Cash and cash equivalents, beginning of the period | 2,235,597 | 2,364,360 |
Cash and cash equivalents, end of the period | 2,070,388 | 2,515,318 |
Schedule of non-cash investing and financing activities: | | |
Automobile financing | 72,650 | 0 |
Declaration on preferred dividend payable | 0 | 4,369,958 |
Conversion of dividends payable related to make-whole amount to common stock | 0 | 4,104,529 |
Deemed dividend on conversion of Series H-1 convertible preferred stock to common stock | 19,724 | 703,770 |
Series F-1 Preferred Stock [Member] | | |
Schedule of non-cash investing and financing activities: | | |
Conversion of dividends payable related to make-whole amount to common stock | 0 | 624,977 |
Series G-1 Preferred Stock [Member] | | |
Schedule of non-cash investing and financing activities: | | |
Conversion of dividends payable related to make-whole amount to common stock | 0 | 212,113 |
Series F And F1 Preferred Stock [Member] | | |
Schedule of non-cash investing and financing activities: | | |
Conversion of preferred stock through the issuance of common stock | 0 | 3,292,741 |
Series G And G1 Preferred Stock [Member] | | |
Schedule of non-cash investing and financing activities: | | |
Conversion of preferred stock through the issuance of common stock | 0 | 1,351,722 |
Series H Preferred Stock [Member] | | |
Schedule of non-cash investing and financing activities: | | |
Conversion of short term convertible note to Series H preferred stock | 0 | 1,299,000 |
Conversion of preferred stock through the issuance of common stock | 219,450 | 865,018 |
Series H-1 Preferred Stock [Member] | | |
Schedule of non-cash investing and financing activities: | | |
Conversion of preferred stock through the issuance of common stock | 36,920 | 0 |
Deemed dividend on conversion of Series H-1 convertible preferred stock to common stock | $ 19,724 | $ 0 |